Fox Run Management, L.L.C. Nuvasive Inc Transaction History

Fox Run Management, L.L.C.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$42.51 - $54.02 $1.11 Million - $1.41 Million	26,034 Added 573.31%	30,575 $1.34 Million
Q2 2022 Aug 12, 2022	BUY	$46.84 - $59.75 $212,700 - $271,324	4,541 New	4,541 $223,000
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $218,419 - $278,399	-3,583 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$55.78 - $68.08 $199,859 - $243,930	3,583 New	3,583 $227,000
Q1 2019 Oct 17, 2019	SELL	$44.53 - $58.9 $181,504 - $240,076	-4,076 Closed	0 $0

Q4 2018 Jan 15, 2019	SELL	$47.64 - $71.26 $327,143 - $489,342	-6,867 Reduced 62.75%	4,076 $202,000
Q3 2018 Oct 05, 2018	BUY	$52.03 - $71.41 $569,364 - $781,439	10,943 New	10,943 $777,000
Q1 2018 Apr 17, 2018	SELL	$46.03 - $61.28 $1.16 Million - $1.54 Million	-25,115 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$50.58 - $60.79 $1.27 Million - $1.53 Million	25,115	25,115 $1.47 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.